ACVR2B Antibody
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


ACVR2B Antibody
Background :
Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor.NCBI Gene ID :
93Swiss Prot :
Q13705Host :
RabbitReactivity :
HumanImmunogen :
A synthetic peptide corresponding to a sequence within amino acids 50-150 of human ACVR2B (NP_001097.2) .Clonality :
PolyclonalConjugation :
UnconjugatedType :
Primary AntibodiesField of Research :
Cell Cycle, Signal Transduction, Stem CellPurification :
Affinity purificationPositive Control :
U-87MGConcentration :
Batch dependentBuffer :
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.Modification :
NoneShipping Conditions :
Blue IceStorage Conditions :
Store at -20˚ C. Avoid freeze / thaw cycles.Calculated Molecular Weight :
Observed: 58kDaFragment :
IgGSymbol :
ACVR2BPositive Control 2 :
K-562NCBI Official Name :
Activin A receptor, type IIBNCBI Organism :
Homo sapiensOther Product Names :
ACVR2B, HTX4, ACTRIIB, ActR-IIBTested Applications :
WB, IFPhysical Properties :
Liquid

